All-newsletter | Reva Pharma

ALL NEWSLETTERS

January 2020

Mission 2020, A Revised Agenda for Indian Pharma

December 2019

Biosimilars in 2020: All Eyes on How Indian Pharmas Cash In...

November 2019

India’s Increased Dependence on Chinese APIs Causing Concern

October 2019

Cancer Research With Homeopathy Reveal Killing Cancer Cells in Lab...

September 2019

Heart-burn for Pharma Firms: After Valsartan, FDA Red-flags...

August 2019

Cancer Burden Rises to 18.1 Million New Cases and 9.6 Million Cance...

July 2019

Japanese Firms Have Generally Cracked the Code of Working in India's H

June 2019

'Gilead's Key Drug Used In HIV-Related Infection Out Of Reach In Developing Countries'

May 2019

Congressman, Industry and Doctors Favour Accelerated Traction on India

April 2019

Indian Pharmaceutical Industry Scores on Compliance with USFDA

December 2018

Drug Firms Expect Pricing Pressure to Stabilise in US

November 2018

USFDA Drug Approvals at All-time High; Indian Firms Get 35-40% of Nods

© Copyright 2015 - All Rights Reserved Reva Pharma. Designed & Developed by Designing Artz
Updated On 16-05-2019